For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest
"Probably any words I use to describe my emotions at seeing this data will understate it," said Daniel Skovronsky, Eli Lilly's head scientist.
If you flip to the 1,031st page of the May 1998 edition of the Journal of Cell Biology, you’ll find the first scientific byline for Daniel Skovronsky, then a young trainee at the University of Pennsylvania, on an article describing how beta-amyloid, a vexing molecule thought to play a role in Alzheimer’s disease, was more complicated than the field understood.
“I’ve been pursuing the same enemy for 25 years,” Skovronsky, now head of research at Eli Lilly, said at the STAT Breakthrough Summit in San Francisco on Wednesday.
What's Your Reaction?
